MAP2K7 and ovarian carcinoma: Indeed, PROCR has a tumor promoting effect and its silencing in gastric cancer inhibits the proliferation and migration via the ERK1/2 pathway, while, in ovarian cancer cells, it induces cell migration via MEK-ERK and Rho-GTPase pathways [65].